<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02816047</url>
  </required_header>
  <id_info>
    <org_study_id>KardioScherr1</org_study_id>
    <nct_id>NCT02816047</nct_id>
  </id_info>
  <brief_title>Austrian Wearable Cardioverter Defibrillator Registry</brief_title>
  <official_title>Indications for and Experience With the Wearable Cardioverter Defibrillator (WCD) - Austrian WCD Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The wearable cardioverter defibrillator (WCD) is an established treatment option
      for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF),
      either in whom this risk may only be temporarily present, or in patients at high risk for
      sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator
      (ICD is currently not possible for other reasons (infection, recent MI &lt;40days, recent
      PCI/CABG &lt; 3months etc.).

      Methods: Comprehensive registry including all patients in Austria who received a WCD in
      2010-2016.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational study to describe WCD indications, event rates, inappropriate shock rates and
      follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD
      patients
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants treated with WCD-treated ventricular arrhythmias</measure>
    <time_frame>during WCD wearing period; average of 1 year</time_frame>
    <description>Number of participants treated with WCD-treated ventricular arrhythmias</description>
  </primary_outcome>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Heart Failure</condition>
  <condition>Ventricular Dysfunction</condition>
  <condition>Sudden Death</condition>
  <condition>Sudden Cardiac Arrest</condition>
  <condition>Ventricular Tachycardia</condition>
  <condition>Ventricular Fibrillation</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Registry</intervention_name>
    <description>Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Comprehensive registry including all patients in all Austrian centers who received a WCD in
        2010-2016.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients, with a prescribed WCD according to guidelines in an austrian center
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Scherr, Assoz. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz/ Division of Cardiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Scherr, Assoz. Prof.</last_name>
    <phone>004331638512544</phone>
    <email>daniel.scherr@medunigraz.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Graz/ Division of Cardiology</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanja Odeneg, MSc</last_name>
      <phone>004331638530199</phone>
      <email>tanja.odeneg@medunigraz.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Graz</investigator_affiliation>
    <investigator_full_name>Scherr Daniel, MD</investigator_full_name>
    <investigator_title>Austrian Wearable Cardioverter Defibrillator Registry</investigator_title>
  </responsible_party>
  <keyword>wearable cardioverter defibrillator</keyword>
  <keyword>LifeVest</keyword>
  <keyword>sudden death</keyword>
  <keyword>defibrillator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Death, Sudden</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>possible</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

